Home > Healthcare > Drug Device Combination > Drug Filled Devices > Mucosal Atomization Device Market

Mucosal Atomization Device Market Trends

Report ID: GMI9181
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Mucosal Atomization Device Market Trends

Continuous advancements in Mucosal Atomization Device (MAD) technology, including enhancements in atomization efficiency, device design, and materials, have positioned them as highly effective drug delivery solutions over conventional solutions such as nasal sprays, for treating challenging conditions like chronic sinusitis and allergic rhinitis.
Moreover, to overcome limited compatibility, the key focus of mucosal atomization device manufacturers can be observed in developing devices that are compatible with a wide array of medications, such as aqueous solutions, suspensions, and viscous drugs. Such enhancements in compatibility of mucosal atomization devices towards newer medications are expected to offer promising growth potential across new applications during the forecast period.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Mucosal atomization device industry size recorded over USD 712.3 million in 2023 and is expected to depict 7.4% CAGR from 2024 to 2032, owing to the rising prevalence of respiratory illnesses, and the expanding adoption of intranasal drug delivery systems

The nasal atomization devices segment in the market accumulated 36.6% share in 2023 and is estimated to grow at substantial CAGR between 2024 and 2032, on account of the surging incidences of respiratory illness.

North America mucosal atomization device industry is projected to be worth USD 498.9 million by 2032, due to the robust presence of advanced healthcare facilities, high demand for non-invasive drug delivery solutions, and the increasing cases of respiratory illness.

Becton, Dickinson, and Co., BTME Group Ltd. (Medtree), BVM Meditech Pvt. Ltd., Cook Medical, Inc., DeVilbiss Healthcare LLC, Intersurgical Ltd., Kurve Therapeutics, Life-Assist Inc., Medica Holdings, LLC, Medspray, Pulmodyne, Inc., and Teleflex Inc. are some of the leading mucosal atomization device companies worldwide.